Nutriband Inc.
NTRB
Rank in Stocks
#21161
Nutriband Inc. specializes in developing a diverse range of pharmaceutical... Nutriband Inc. specializes in developing a diverse range of pharmaceutical products delivered via transdermal patches. The company's most advanced program centers on AVERSA fentanyl, an innovative fentanyl transdermal system engineered to prevent abuse. This extended-release patch provides healthcare professionals and patients with a continuous opioid therapy solution for the ongoing management of chronic pain. Its development pipeline also includes other treatments, such as AVERSA buprenorphine and AVERSA methylphenidate. Additionally, Nutriband is working on exenatide for individuals with type 2 diabetes and follicle stimulating hormone as a treatment for infertility. The company also holds a licensing agreement with Rambam Med-Tech Ltd. to further the development of RAMBAM Closed System Transfer Devices. Nutriband Inc. was founded in 2016 and its main offices are located in Orlando, Florida.
Share Price
$5.96
Last synced: 2026-11-09
Market Cap
$72.45M
Change (1 day)
7.39%
Change (1 year)
-2.13%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Nutriband Inc. (NTRB)
Category
Healthcare
EPS for Nutriband Inc. (NTRB)
EPS as of July 2026 TTM: $-0.57
According to Nutriband Inc.'s latest financial reports, its current EPS (TTM) is $-0.57. At the end of 2025 the company had an EPS of $-0.99, a decrease compared to its 2024 EPS of $-0.69.
EPS history for Nutriband Inc. from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.57 | -42.42% |
| 2025 | $-0.99 | 43.48% |
| 2024 | $-0.69 | 21.05% |
| 2023 | $-0.57 | -46.23% |
| 2022 | $-1.06 | 120.83% |
| 2021 | $-0.48 | 9.09% |
| 2020 | $-0.44 | -16.98% |
| 2019 | $-0.53 | 10.42% |
| 2018 | $-0.48 | 1,820.00% |
| 2017 | $-0.03 | 24,900.00% |
| 2016 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -2,847.37% |
US
|
|
| $-7.07 | 1,140.35% |
US
|
|
| $-5.29 | 828.07% |
AU
|
|
| $12.88 | -2,359.67% |
BE
|
|
| $21.56 | -3,882.46% |
NL
|
Questions about Nutriband Inc.'s earnings per share (EPS)
What is Nutriband Inc.'s earnings per share (EPS)?
Nutriband Inc.'s earnings per share (EPS) over the last twelve months is $-0.57, as of Jul 2026.
What was Nutriband Inc.'s earnings per share (EPS) in 2025?
In 2025, Nutriband Inc.'s earnings per share (EPS) was $-0.99, compared with $-0.69 in 2024.
How has Nutriband Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Nutriband Inc.'s earnings per share (EPS) was highest in 2020 ($-0.44) and lowest in 2022 ($-1.06).
How does Nutriband Inc.'s earnings per share (EPS) compare with similar companies?
Nutriband Inc.'s earnings per share (EPS) ($-0.57) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.